TUBITAK BILGEM Software Technologies Research Institute
Vulnerability activity for TUBITAK BILGEM Software Technologies Research Institute: what is being exploited, what was published lately, and when the next patch release is due.
Last 30 days
- CVEs
- 0
- Critical (CVSS 9+)
- 0
- Exploited (CISA KEV)
- 0
- With exploit code
- 0
Last 90 days
- CVEs
- 1
- Critical (CVSS 9+)
- 0
- Exploited (CISA KEV)
- 0
- With exploit code
- 0
Last 365 days
- CVEs
- 3
- Critical (CVSS 9+)
- 0
- Exploited (CISA KEV)
- 0
- With exploit code
- 0
Exploited now
None of this vendor's CVEs are on CISA's known-exploited list.
Recent
- 7.8HighAug 3, 2026TUBITAK BILGEM Software Technologies Research Institute eta-otp-lock DeserializationCVE-2026-18642Deserialization of untrusted data vulnerability in TUBITAK BILGEM Software Technologies Research Institute eta-otp-lock allows Object Injection. This issue affects eta-otp-lock: before 1.0.4.
- 8.8HighApr 29, 2026TUBITAK BILGEM Software Technologies Research Institute Pardus Software Center Privilege escalationCVE-2026-5141Improper Privilege Management, Improper Access Control, Incorrect privilege assignment vulnerability in TUBITAK BILGEM Software Technologies Research Institute Pardus Software Center allows Hijacking a privileged process. This issue affects Pardus Software Center: from 1.0.2 before 1.0.3.
- 8.8HighApr 29, 2026TUBITAK BILGEM Software Technologies Research Institute Pardus Update Auth bypass / access controlCVE-2026-5140Improper neutralization of CRLF sequences ('CRLF injection') vulnerability in TUBITAK BILGEM Software Technologies Research Institute Pardus Update allows Authentication Bypass. This issue affects Pardus Update: from 0.6.3 before 0.6.4.
See every TUBITAK BILGEM Software Technologies Research Institute entry on the dashboard.
Top products
- Pardus Update1 CVE in the last year
- Pardus Software Center1 CVE in the last year
- eta-otp-lock1 CVE in the last year
Counts cover CVEs and advisories Watch Floor tracks, by the date they became news. Updated every 10 minutes.